Literature DB >> 10759951

Neutrophil and endothelial cell activation in the vasa vasorum in vasculo-Behçet disease.

M Kobayashi1, M Ito, A Nakagawa, M Matsushita, N Nishikimi, T Sakurai, Y Nimura.   

Abstract

AIM: The aim of this study was to analyse the immunopathological mechanisms of vasculo-Behçet disease, which were also compared to cases of Takayasu's arteritis and inflammatory aneurysm to evaluate differences in inflammatory mechanisms. METHOD AND
RESULTS: We reviewed six cases of vasculo-Behçet disease, four of Takayasu's arteritis and seven inflammatory aneurysms which underwent surgical repair. Immunohistochemical studies were performed on paraffin-embedded tissue using a labelled streptavidin-biotin method, as was in-situ hybridization for Epstein-Barr virus. Microscopically, neutrophils and lymphocytes accumulated around the vasa vasorum. Neutrophils were prominent as compared to Takayasu's arteritis and inflammatory aneurysm. Elastic fibres were not severely destroyed. Endothelial cells (ECs) of most vasa vasorum expressed HLA-DR. The number of vasa vasorum around which inflammatory infiltrating cells were observed in vasculo-Behçet disease was significantly greater than in inflammatory aneurysms and Takayasu's arteritis (P < 0.001). The cytokines IL-1alpha, TNF-beta and IFN-gamma were expressed in neutrophils and lymphocytes which were distributed around vasa vasorum, as well as neutrophils adherent to HLA-DR positive ECs.
CONCLUSION: Our results suggest that vasculo-Behçet disease should be classified as a neutrophilic vasculitis targeting the vasa vasorum. Aneurysm formation may be related to degeneration of arterial wall caused by inflammation of the vasa vasorum.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10759951     DOI: 10.1046/j.1365-2559.2000.00859.x

Source DB:  PubMed          Journal:  Histopathology        ISSN: 0309-0167            Impact factor:   5.087


  31 in total

Review 1.  Adamantiades-Behcet's disease-complicated gastroenteropathy.

Authors:  Qing-Jun Wu; Feng-Chun Zhang; Xuan Zhang
Journal:  World J Gastroenterol       Date:  2012-02-21       Impact factor: 5.742

Review 2.  Innate immune cells in the pathogenesis of primary systemic vasculitis.

Authors:  Durga Prasanna Misra; Vikas Agarwal
Journal:  Rheumatol Int       Date:  2015-09-24       Impact factor: 2.631

3.  Assessment of aortic stiffness and ventricular diastolic functions in patients with Behçet's disease.

Authors:  S Ercan Tunc; Abdullah Dogan; Omer Gedikli; Cagatay Arslan; Mehmet Sahin
Journal:  Rheumatol Int       Date:  2005-02-23       Impact factor: 2.631

Review 4.  The unique features of vasculitis in Behçet's syndrome.

Authors:  Melike Melikoglu; Emire Kural-Seyahi; Koray Tascilar; Hasan Yazici
Journal:  Clin Rev Allergy Immunol       Date:  2008-10       Impact factor: 8.667

Review 5.  Gastrointestinal manifestations of Behçet's disease.

Authors:  Ellen C Ebert
Journal:  Dig Dis Sci       Date:  2008-07-02       Impact factor: 3.199

Review 6.  Biological therapies for the treatment of Behçet's disease-related uveitis beyond TNF-alpha blockade: a narrative review.

Authors:  Jurgen Sota; Donato Rigante; Giuseppe Lopalco; Bruno Frediani; Rossella Franceschini; Mauro Galeazzi; Florenzo Iannone; Gian Marco Tosi; Claudia Fabiani; Luca Cantarini
Journal:  Rheumatol Int       Date:  2017-07-27       Impact factor: 2.631

7.  Acute inferior myocardial infarction in a young male patient associated with Behcet's disease and sildenafil.

Authors:  Mustafa Cetin; Unal Ozturk; Musa Cakici; Emrah Yildiz
Journal:  BMJ Case Rep       Date:  2014-01-21

8.  Auditory involvement in Behcet's disease: relationship with demographic, clinical, and therapeutic characteristics.

Authors:  Jurgen Sota; Antonio Vitale; Ida Orlando; Giuseppe Lopalco; Rossella Franceschini; Claudia Fabiani; Mauro Galeazzi; Giacomo Emmi; Stefano Gentileschi; Florenzo Iannone; Bruno Frediani; Luca Cantarini
Journal:  Clin Rheumatol       Date:  2016-07-31       Impact factor: 2.980

9.  Panuveitis simulating ocular Behçet's in cases of chronic myelogenous leukaemia in remission.

Authors:  Rohan Chawla; Koushik Tripathy
Journal:  BMJ Case Rep       Date:  2017-11-23

Review 10.  Behcet's Syndrome.

Authors:  Sam R Dalvi; Resit Yildirim; Yusuf Yazici
Journal:  Drugs       Date:  2012-12-03       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.